CTAP
This highly potent and selective μ opioid receptor antagonist exhibits an IC50 of 3.5 nM with over 1200-fold selectivity for δ opioid and somatostatin receptors. Its brain-penetrant properties make it a valuable pharmacological tool for in vivo studies of pain, addiction, and reward pathways, as well as for in vitro receptor characterization.
Product Specifications
Field of Research
Metabolism Research, Neuroscience, Pharmacology & Drug Discovery
Molecular Weight
1104.32
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog